论文部分内容阅读
甲胎蛋白是诊断原发性肝癌的传统肝癌标志物,但约有 30％-40％的原发性肝癌甲胎蛋白阴性。因而其他的肝癌标志物,如CA19-9等也应用于原发性肝癌的诊断。本研究旨在探讨CA19-9在原发性肝癌诊断中的临床意义。
Alpha-fetoprotein is a traditional liver cancer marker for the diagnosis of primary liver cancer, but about 30% -40% of primary liver cancers are alpha-fetoprotein negative. Therefore, other liver cancer markers, such as CA19-9, are also used in the diagnosis of primary liver cancer. This study aimed to investigate the clinical significance of CA19-9 in the diagnosis of primary liver cancer.